Such consideration is even more reasonable owing to PD-1 being significantly upregulated in PBMCs of patients suffering from postmenopausal osteoporosis, which represents an imbalance in the OC/OB activity ratio and further correlates with elevated C-reactive protein (CRP) levels (2). This evidence concerns the gene CRP and postmenopausal osteoporosis.